Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.280
-0.030 (-0.91%)
Feb 18, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2015FY 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '15 Dec '14
Diagnostic Kits / Equipment
55.64M52.55M45.56M48.30M41.98M
Diagnostic Kits / Equipment Growth
5.89%15.33%-5.66%15.07%3.93%
Total
55.64M52.55M45.56M48.30M41.98M
Total Growth
5.89%15.33%-5.66%15.07%3.93%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2015FY 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '15 Dec '14
United States
55.64M52.55M45.56M48.30M41.98M
United States Growth
5.89%15.33%-5.66%15.07%3.93%
Total
55.64M52.55M45.56M48.30M41.98M
Total Growth
5.89%15.33%-5.66%15.07%3.93%
Source: S&P Global Market Intelligence.